905439-45-4 Usage
Uses
Used in Pharmaceutical Industry:
2-(2-Methyl-3-butyn-2-ol)-4-aMinotoluene is used as an intermediate in the synthesis of pyrimidine derivatives, which are important building blocks for the development of various pharmaceutical compounds. These pyrimidine derivatives have potential applications in the treatment of various diseases, including cancer, viral infections, and inflammatory conditions.
Used in Chemical Synthesis:
2-(2-Methyl-3-butyn-2-ol)-4-aMinotoluene is also used as a versatile intermediate in the synthesis of various organic compounds, such as dyes, pigments, and other specialty chemicals. Its unique structure allows for a wide range of chemical reactions, making it a valuable component in the development of new materials and products.
Check Digit Verification of cas no
The CAS Registry Mumber 905439-45-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,0,5,4,3 and 9 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 905439-45:
(8*9)+(7*0)+(6*5)+(5*4)+(4*3)+(3*9)+(2*4)+(1*5)=174
174 % 10 = 4
So 905439-45-4 is a valid CAS Registry Number.
905439-45-4Relevant academic research and scientific papers
Aminopyrimidine Derivatives With Tie2 Inhibiting Activity
-
Page/Page column 43, (2008/12/07)
The invention relates to a compound of the Formula I or salt thereof wherein Rx, Ry, Rx, R5, R6, A, B, L, n and m are as defined in the description. The invention also relates to pharmaceutical compositions of said compounds, the use of said compounds as medicaments and in the production of an anti-angiogenic effect in a warm blooded animal. The invention also relates to processes for the preparation of said compounds.
PYRIMIDINE COMPOUNDS HAVING TIES (TEK) INHIBITORY ACTIVITY
-
Page/Page column 112, (2008/06/13)
The invention relates to a compound of the Formula (I) or salt thereof wherein Rx, Ry, Rz, R5, R6, A, B, L, n and m are as defined in the description. The invention also relates to pharmaceutical compositions of said compounds, the use of said compounds as medicaments and in the production of an anti-angiogenic effect in a warm blooded animal. The invention also relates to processes for the preparation of said compounds.
